|
|
|
| Mastering Aseptic Fill-Finish | Dec. 1, 2026, 11:00 AM ET | This session explores aseptic fill-finish manufacturing, focusing on contamination control, regulatory compliance, and sterile processing best practices. Industry experts will discuss the value of early sponsor-CDMO collaboration, effective program planning, platform technologies, and quality-focused manufacturing strategies. Attendees will gain insights into maintaining product integrity, supporting successful scale-up, and ensuring commercial readiness through every stage of fill-finish operations. |
|
|
|
| Sample-Attribute-Based Selection Strategies For AAV %Full Determination | White Paper | By Wonil Chae, Abigail De La Peña, Junhee Han, et al., Samsung Biologics | AAV %Full analysis must distinguish full, empty, and partial capsids, with complementary methods selected according to sample characteristics, analytical needs, development stage, and context. |
|
|
|
|
|
|
By Jeffrey S. Buguliskis, Ph.D., Deputy Chief Editor, Outsourced Pharma | Over two days in Boston, biopharma leaders at CDMO Live Americas confronted a blunt truth: the outsourcing sector doesn't lack ambition or stainless steel, it has a widening gap between partnership intent and shop-floor delivery. | |
|
|
|
By Dora Wells, Editor of PharmaSource and Conference Producer | 112 pages of executive insight from CDMO Live Europe 2026: tariffs, geopolitics, supply resilience, AI in manufacturing, and why strategic partnerships remain aspirational for most. | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| A Smooth Transition To USP <382> With Established Expertise | Q&A | BD Medical - Pharmaceutical Systems | A new regulatory chapter requires holistic, real‑world testing of injectable systems, mandating full‑system validation with actual drug products and prioritizing patient‑centric performance and safety. |
|
|
| Flow Chemistry For Contemporary Isotope Labeling | Article | By Mounir Raji, X-Chem | View how late‑stage exchange and flow‑based methods enable efficient access to labeled molecules for pharmaceuticals, mechanistic studies, and analytical applications. |
|
|
| Avoid CapEX With Improved Operational Efficiencies | Case Study | Thermo Fisher Scientific Bioproduction | Avoid massive capital expenditures by optimizing supply chain logistics. Assimilate how off-site material sampling and just-in-time delivery reduce lead times from eight weeks to a single day. |
|
|
| Innovations In Perfusion Bioprocessing | Webinar | Cytiva | Gain valuable insight into the optimization and scalability of perfusion media and processes, driving progress in biotechnological processes for monoclonal antibody production. |
|
|
|
|
| Sterile Fill Finish Manufacturing At Scale | Article | Syngene International Ltd. | Upstream decisions directly dictate late-stage sterile fill-finish success. Read how aligning drug substance synthesis, formulation design, and aseptic filling early mitigates operational risks. |
|
|
|
|
| Where Formulation Expertise Connects | Article | Coriolis Pharma | As pipelines grow more complex and timelines become more ambitious, companies increasingly rely on strong external partners to advance their drug products efficiently and with reduced risk. |
|
|
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|